Full-dose CHOP chomotherapy in elderly patients with non-Hodgkin's lymphoma

被引：0
|
作者：
Epeilbaum, R.
Hain, N.
Leblor, M.
Ben-Shahar, M.
Ben-Arie, Y.
Dror, Y.
Faraggi, D.
机构：
来源：
Acta Oncologica | / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinical trials in non-Hodgkin's Lymphoma in elderly patients
    Sonneveld, P.
    Doorduijn, J. J.
    Lugtenburg, P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S12 - S12
  • [22] DOSE INTENSITY IN HODGKIN AND NON-HODGKIN'S LYMPHOMA
    Mariz, J. M.
    Teixeira, A.
    Pereira, A. Marques
    Santo, J. Espirito
    Marques, M.
    Magalhaes, E.
    Portela, C.
    Trindade, M. C.
    Costa, R.
    Oliveira, I.
    Vieira, R.
    Marques, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 176 - 176
  • [23] Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma
    Kikuchi, Misato
    Nakasone, Hideki
    Akahoshi, Yu
    Nakano, Hirofumi
    Ugai, Tomotaka
    Wada, Hidenori
    Yamasaki, Ryoko
    Sakamoto, Kana
    Kawamura, Koji
    Ishihara, Yuko
    Sato, Miki
    Ashizawa, Masahiro
    Terasako-Saito, Kiriko
    Kimura, Shun-ichi
    Yamazaki, Rie
    Kako, Shinichi
    Kanda, Junya
    Nishida, Junji
    Sekiguchi, Naohiro
    Noto, Satoshi
    Kida, Michiko
    Hangaishi, Akira
    Usuki, Kensuke
    Kanda, Yoshinobu
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (02) : 99 - 105
  • [24] Case studies of elderly patients with non-Hodgkin's lymphoma
    Luminari, Stefano
    Federico, Massimo
    HEMATOLOGY REPORTS, 2011, 3 : 20 - 22
  • [25] Chop chemotherapy in non-Hodgkin's lymphoma: Prognostic factors in 123 patients
    Pedro, C
    Besses, C
    Paez, A
    Acin, P
    Monzo, S
    Asensio, A
    SansSabrafen, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1376 - 1376
  • [26] Impact of full dose of rituximab on pharmacokinetics and dosimetry of Zevalin for patients with non-Hodgkin's lymphoma
    Shen, S
    Forero, A
    Meredith, RF
    LoBoglio, AF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S426 - S426
  • [27] Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma -: a phase II study
    Späth-Schwalbe, E
    Lange, C
    Genvresse, I
    Krüuger, L
    Eucker, J
    Schweigert, M
    Sezer, O
    Budach, V
    Possinger, K
    ANTI-CANCER DRUGS, 2002, 13 (04) : 395 - 403
  • [28] Side effects of CHOP in the treatment of non-Hodgkin's lymphoma
    Sitzia, J
    North, C
    Stanley, J
    Winterberg, N
    CANCER NURSING, 1997, 20 (06) : 430 - 439
  • [29] CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma - Reply
    Doorduijn, JK
    Sonneveld, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4799 - 4800
  • [30] Short high-dose CHOP chemotherapy for aggressive non-Hodgkin's lymphoma (NHL).
    Epelbaum, R
    Dann, E
    Drumea, K
    Haim, N
    Ben-Shahar, M
    Faraggi, D
    Rowe, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 584S - 584S
12345